
    
      The study is designed as a multi-center prospective trial with one arm. There will be 5
      centers participating the study. Patients diagnosed with early-stage non-small cell lung
      cancer (NSCLC) that are nonsurgical candidate will be enrolled in the study. Sixty patients
      are expected to be enrolled in the study. The purpose of the study is to evaluate the
      efficacy and safety of ENB guided MWA for the treatment of patients with early-stage
      nonsurgical NSCLC.
    
  